查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1411497

腦疾病模式與軟體市場：依產品類型、病患類型、適應症分類 - 全球預測 2024-2030

Brain Disease Modalities & Software Market by Product (Brain Analysis Software, Brain Imaging Modalities), Patient Type (Adults, Infants, Pediatrics), Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年腦部疾病模式和軟體市場規模為151.8億美元，2024年達到161.1億美元，2030年預計將達218.4億美元，複合年成長率為5.33%。

腦疾病治療方式與軟體的全球市場

主要市場統計
基準年[2023] 151.8億美元
預測年份 [2024] 161.1億美元
預測年份 [2030] 218.4億美元
複合年成長率（%） 5.33%
腦疾病模式與軟體市場-IMG1

FPNV定位矩陣

FPNV 定位矩陣對於評估腦部疾病模式和軟體市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出資訊的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對腦疾病模式和軟體市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更資訊的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-腦疾病模式和軟體市場的市場規模和預測是多少？

2-在腦疾病模式和軟體市場預測期內需要考慮投資的產品、細分市場、應用程式和領域有哪些？

3-腦疾病模式和軟體市場的技術趨勢和法律規範是什麼？

4-腦疾病模式和軟體市場主要供應商的市場佔有率是多少？

5-進入腦疾病模態和軟體市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高對腦​​部疾病的盛行率和診斷的認知
      • 政府鼓勵在腦部疾病管理中使用數位解決方案的舉措
      • 在腦部疾病檢測中擴大採用神經影像方法
    • 抑制因素
      • 將軟體技術整合到測試設備中的複雜性
    • 機會
      • 基於人工智慧和機器學習的先進腦部疾病軟體簡介
      • 投資擴建及建立腦部疾病治療中心
    • 任務
      • 與資料隱私和安全漏洞相關的擔憂
  • 市場區隔分析
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章腦疾病模式與軟體市場：依產品

  • 大腦分析軟體
  • 腦部影像診斷方法
    • CT設備
    • 核磁共振造影系統
    • PET裝置
    • PET-CT
    • PET-MRI

第 7 章依病患類型分類的腦疾病模式與軟體市場

  • 成人
  • 嬰兒
  • 小兒科

第8章依適應症分類的腦疾病模式與軟體市場

  • 腦部疾病
    • 腦腫瘤
    • 中樞神經系統癌症
    • 特發性癲癇
    • 缺血性中風
  • 神經退化性疾病
    • 阿茲海默症
    • 運動神經疾病
    • 多發性硬化症
    • 帕金森氏症

第9章美洲腦疾病模式與軟體市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太腦疾病治療方式與軟體市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的腦疾病模式與軟體市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析

第13章競爭產品組合

  • 主要公司簡介
    • Aspect Imaging Ltd.
    • Brainomix Limited
    • Canon Medical Systems Corporation
    • Carestream Health, Inc.
    • Esaote SpA
    • Fujifilm Holdings Corporation
    • General Electric Company,
    • Imaging Biometrics LLC
    • International Business Machines Corporation
    • IXICO plc.
    • Koninklijke Philips NV,
    • MIM Software, Inc.
    • Quantib BV
    • ScienceSoft USA Corporation
    • Siemens Healthineers AG
    • VUNO Inc.
  • 主要產品系列

第14章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-5C6F41F5AFA8

[194 Pages Report] The Brain Disease Modalities & Software Market size was estimated at USD 15.18 billion in 2023 and expected to reach USD 16.11 billion in 2024, at a CAGR 5.33% to reach USD 21.84 billion by 2030.

Global Brain Disease Modalities & Software Market

KEY MARKET STATISTICS
Base Year [2023] USD 15.18 billion
Estimated Year [2024] USD 16.11 billion
Forecast Year [2030] USD 21.84 billion
CAGR (%) 5.33%
Brain Disease Modalities & Software Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Brain Disease Modalities & Software Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Brain Disease Modalities & Software Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Brain Disease Modalities & Software Market, highlighting leading vendors and their innovative profiles. These include Aspect Imaging Ltd., Brainomix Limited, Canon Medical Systems Corporation, Carestream Health, Inc., Esaote S.p.A., Fujifilm Holdings Corporation, General Electric Company,, Imaging Biometrics LLC, International Business Machines Corporation, IXICO plc., Koninklijke Philips N.V.,, MIM Software, Inc., Quantib B.V., ScienceSoft USA Corporation, Siemens Healthineers AG, and VUNO Inc..

Market Segmentation & Coverage

This research report categorizes the Brain Disease Modalities & Software Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Brain Analysis Software
    • Brain Imaging Modalities
      • CT Devices
      • MRI Devices
      • PET Devices
      • PET-CT
      • PET-MRI
  • Patient Type
    • Adults
    • Infants
    • Pediatrics
  • Indication
    • Brain Diseases
      • Brain Cancer
      • Central Nervous System Cancer
      • Idiopathic Epilepsy
      • Ischemic Stroke
    • Neurodegenerative Diseases
      • Alzheimer's Disease
      • Motor Neuron Disease
      • Multiple Sclerosis
      • Parkinson's Disease
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Brain Disease Modalities & Software Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Brain Disease Modalities & Software Market?

3. What are the technology trends and regulatory frameworks in the Brain Disease Modalities & Software Market?

4. What is the market share of the leading vendors in the Brain Disease Modalities & Software Market?

5. Which modes and strategic moves are suitable for entering the Brain Disease Modalities & Software Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Brain Disease Modalities & Software Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of brain disorders and increasing awareness regarding seeking diagnosis
      • 5.1.1.2. Government initiatives encouraging the use of digital solutions in brain disease management
      • 5.1.1.3. Increasing adoption of neuroimaging modalities for brain disease testing
    • 5.1.2. Restraints
      • 5.1.2.1. Complexities of integrating software technologies in testing equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of advanced brain disease software based on AI and ML
      • 5.1.3.2. Investments in the expansion and establishment of brain disease treatment centers
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with data privacy and security breaches
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Brain Disease Modalities & Software Market, by Product

  • 6.1. Introduction
  • 6.2. Brain Analysis Software
  • 6.3. Brain Imaging Modalities
    • 6.4.1. CT Devices
    • 6.4.2. MRI Devices
    • 6.4.3. PET Devices
    • 6.4.4. PET-CT
    • 6.4.5. PET-MRI

7. Brain Disease Modalities & Software Market, by Patient Type

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Infants
  • 7.4. Pediatrics

8. Brain Disease Modalities & Software Market, by Indication

  • 8.1. Introduction
  • 8.2. Brain Diseases
    • 8.3.1. Brain Cancer
    • 8.3.2. Central Nervous System Cancer
    • 8.3.3. Idiopathic Epilepsy
    • 8.3.4. Ischemic Stroke
  • 8.3. Neurodegenerative Diseases
    • 8.4.1. Alzheimer's Disease
    • 8.4.2. Motor Neuron Disease
    • 8.4.3. Multiple Sclerosis
    • 8.4.4. Parkinson's Disease

9. Americas Brain Disease Modalities & Software Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Brain Disease Modalities & Software Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Brain Disease Modalities & Software Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Aspect Imaging Ltd.
    • 13.1.2. Brainomix Limited
    • 13.1.3. Canon Medical Systems Corporation
    • 13.1.4. Carestream Health, Inc.
    • 13.1.5. Esaote S.p.A.
    • 13.1.6. Fujifilm Holdings Corporation
    • 13.1.7. General Electric Company,
    • 13.1.8. Imaging Biometrics LLC
    • 13.1.9. International Business Machines Corporation
    • 13.1.10. IXICO plc.
    • 13.1.11. Koninklijke Philips N.V.,
    • 13.1.12. MIM Software, Inc.
    • 13.1.13. Quantib B.V.
    • 13.1.14. ScienceSoft USA Corporation
    • 13.1.15. Siemens Healthineers AG
    • 13.1.16. VUNO Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET RESEARCH PROCESS
  • FIGURE 2. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET DYNAMICS
  • FIGURE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 9. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CT DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MRI DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-CT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PET-MRI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 21. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY CENTRAL NERVOUS SYSTEM CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY IDIOPATHIC EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ISCHEMIC STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 27. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY ALZHEIMER'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MOTOR NEURON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PARKINSON'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 84. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 90. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 94. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 96. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 100. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 102. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 106. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 108. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 112. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 114. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 118. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 120. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 130. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 132. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 136. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 138. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 142. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 144. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 157. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 161. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 163. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 167. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 169. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 173. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 175. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 179. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 181. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 185. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 187. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 191. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 193. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 203. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 205. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 209. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 211. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 215. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 217. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 221. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 223. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 227. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 228. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 229. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 242. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 245. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 246. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 247. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 248. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 251. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 253. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 258. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 263. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 265. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN IMAGING MODALITIES, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY BRAIN DISEASES, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM BRAIN DISEASE MODALITIES & SOFTWARE MARKET SIZE, BY NEURODEGENERATIVE DISEASES, 2018-2030 (USD MILLION)
  • TABLE 281. BRAIN DISEASE MODALITIES & SOFTWARE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 282. BRAIN DISEASE MODALITIES & SOFTWARE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 283. BRAIN DISEASE MODALITIES & SOFTWARE MARKET LICENSE & PRICING